HIV antigens can induce TGF-β1-producing immunoregulatory CD8+ T cells

Journal of Immunology

Volumn 168, Issue 5, 2002, Pages 2247-2254

  Garba, Mohammed L ^a   Pilcher, Christopher D ^a   Bingham, Andrea L ^a   Eron, Joseph ^a   Frelinger, Jeffrey A ^a  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD8 ANTIGEN; GAMMA INTERFERON; HUMAN IMMUNODEFICIENCY VIRUS ANTIGEN; TRANSFORMING GROWTH FACTOR BETA1; VIRUS PROTEIN;

ADULT; ANTIGEN SPECIFICITY; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; CYTOTOXIC T LYMPHOCYTE; FEMALE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE DEFICIENCY; IMMUNOREGULATION; LYMPHOCYTE COUNT; MALE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE; VACCINIA VIRUS;

EID: 0036499256     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.168.5.2247     Document Type: Article

References (51)

1. Human immunodeficiency virus type 1-specific cytotoxic T lymphocyte activity is inversely correlated with HIV type 1 viral load in HIV type 1-infected long-term survivors
2. HIV versus the immune system: Another apparent victory for the virus
3. Substantial differences in specificity of HIV-specific cytotoxic T cells in acute and chronic HIV infection
4. Cellular immune responses and viral diversity in individuals treated during acute and early HIV-1 infection
5. Immunologic reconstitution in the acquired immunodeficiency syndrome
6. + T-cell γ interferon production specific for human immunodeficiency virus type 1 (HIV-1) in HIV-1-infected subjects
7. IL-13 and IFN-γ secretion by activated T cells in HIV-1 infection associated with viral suppression and a lack of disease progression
8. + T cells in HIV infection
9. Longitudinal phenotypic analysis of human immunodeficiency virus type 1-specific cytotoxic T lymphocytes: Correlation with disease progression
10. Cell-mediated suppression of HIV-specific cytotoxic T lymphocytes
11. + T lymphocytes, monocytes, and dendritic cells by cytotoxic T lymphocytes
12. HIV virions and HIV infection in vitro are unaffected by human granzymes A and B
13. RANTES activates antigen-specific cytotoxic T lymphocytes in a mitogen-like manner through cell surface aggregation
14. IFN-γ restores HIV- and non-HIV-specific cell mediated immune response in vitro and its activity is neutralized by antibodies from patients with AIDS
15. Interferon-γ marks activated T lymphocytes in AIDS patients
16. + lymphocytes of patients with AIDS synthesize increased amounts of interferon-γ
17. Detection of intracytoplasmic cytokine using flow cytometry and directly conjugated anti-cytokine antibodies
18. Enumeration of IFN-γ producing lymphocytes by flow cytometry and correlation with quantitative measurement of IFN-γ
19. + subjects
20. Immune interferon release when a cloned cytotoxic T-cell line meets its correct influenza-infected target cell
21. Human immunodeficiency virus type 1-specific cytotoxic T lymphocytes release γ interferon, tumor necrosis factor α (TNF-α), and TNF-β when they encounter their target antigens
22. T-cell epitope mapping by flow cytometry
23. Elevated IFN-γ and decreased IL-2 gene expression are associated with HIV infection
24. - T cells
25. Two forms of transforming growth factor-β distinguished by multipotential haematopoietic progenitor cells
26. HIV-1 Tat: Immunosuppression via TGF-β1 induction
27. Differential expression of cytokine genes in HIV-1 tat transfected T and B cell lines
28. Kinetics of the changes of lymphocyte subsets defined by cytokine production at single cell level during highly active antiretroviral therapy for HIV-1 infection
29. Cytokines and cytokine therapies in HIV infection
30. A simplified plaque technique for titration of pox virus and its antibodies in chick embryo cells
31. + T cell frequencies by flow cytometry: Evidence for a novel, antigen-specific homeostatic mechanism in HIV-associated immunodeficiency
32. + T cells are detectable in most individuals with active HIV-1 infection, but decline with prolonged viral suppression
33. + T cell responses by intracellular cytokine production
34. Use of overlapping peptide mixtures as antigens for cytokine flow cytometry
35. Psoralens potentiate ultraviolet light-induced inhibition of epidermal growth factor binding
36. A possible mechanism of psoralen phototoxicity not involving direct interaction with DNA
37. Detection of antigen-specific T cell cytokine expression in whole blood by flow cytometry
38. Rapid assessment of antigen induced cytokine expression in memory T cells by flow cytometry
39. Intracellular cytokine staining for TGF-β
40. Biological characterization of a monoclonal antibody TB 21 against human transforming growth factor-β1
41. HIV-specific cytotoxic T-lymphocyte activity in immunologically normal HIV-infected persons
42. Cytotoxic T lymphocytes against HIV
43. Increased levels of transforming growth factor-β in HIV-associated nephropathy
44. The expanding universe of T-cell subsets: Th1, Th2 and more
45. Loss of T-cell cytotoxic responses in the course of HIV-1 infection
46. + T cells during the primary immune response to Epstein-Barr virus in vivo
47. Counting antigen-specific CD8 T cells: A reevaluation of bystander activation during viral infection
48. ÷ T cells in chronic HIV infection are antigen specific
49. Transforming growth factor β1 positively regulates its own expression in normal and transformed cells
50. Analysis of the human env-specific cytotoxic T-lymphocyte (CTL) response in natural human immunodeficiency virus type 1 infection: Low prevalence of broadly cross-reactive env-specific CTL
51. Immune control of HIV-1 after early treatment of acute infection